GlassScriptPhysician profile
Ashish Shukla
NPI 1366674889
$739.94
in general payments reported to CMS, 2019-2025
10 companies · $291 in 2025
The $291 reported for 2025 was more than what 75% of Electrodiagnostic Medicine providers received nationally (typical 2025 total: $66.89).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.40 · 2020: $136 · 2023: $76.81 · 2024: $175 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $281.94 | 2020-2025 | Carto 3 |
| Medtronic, INC. | $116.52 | 2025 | Aurora Ev-Icd Mri Surescan |
| Heartflow, INC. | $94.35 | 2024-2025 | |
| Irhythm Technologies, INC. | $66.01 | 2023 | Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $57.96 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $42.14 | 2024 | Optimizer |
| Novo Nordisk INC | $30.63 | 2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $21.16 | 2024 | Amplatzer Amulet |
| Boston Scientific Corporation | $18.43 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.80 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Shukla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.